ArticleScientific reports2025
Machine learning identifies lactate metabolism biomarkers and deciphers immune infiltration landscapes in Parkinson's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD), the second most common neurodegenerative disorder worldwide, is characterized by irreversible neuronal loss. Its progressive motor and non-motor symptoms-including resting tremor, postural instability, and autonomic dysfunction-substantially impair quality of life and impose significant socioeconomic burdens. Current diagnosis relies primarily on subjective motor assessments due to the absence of objective biomarkers, often delaying detection until advanced stages of neurodegeneration. Therefore, identifying PD-specific biomarkers is critical for early diagnosis, targeted interventions, and disease management. Recent evidence suggests a strong association between PD and dysregulated lactate metabolism, involving altered lactate levels, lactylation-dependent epigenetic modifications, and abnormal expression of genes related to lactate metabolism, all contributing to disease pathogenesis. To identify novel biomarkers associated with lactate metabolism for early PD detection, we integrated two GEO datasets as training cohorts. Differential expression analysis identified 119 differentially expressed genes (DEGs), of which 33 overlapped with 5,193 lactate metabolism-related genes. Using machine learning algorithms, including the least absolute shrinkage and selection operator (LASSO) and support vector machine (SVM), we prioritized four candidate biomarkers: KCNJ6, PDK4, LRP2, and DENR. External validation confirmed their diagnostic utility. A nomogram model constructed with these markers demonstrated robust predictive performance for PD. Immune infiltration analysis further revealed distinct immune cell profiles in the substantia nigra of PD patients and their significant correlations with the identified biomarkers. Collectively, these genes associated with lactate metabolism represent promising diagnostic indicators, offering valuable insights for both PD research and clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.